● Recruiting

The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.

Condition: Fever of Unknown Origin · IgG4 Related Disease · Axial Spondylarthritis (axSpA) · Sponsor: Universitaire Ziekenhuizen KU Leuven

PhasePhase 2/Phase 3

Planned participants140

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The aim of the study to evaluate the performance of new \[18F\]-AlF-FAPI-74 PET/CT in three inflammatory disorders (fever of unknown origin, IgG4-related disease and axial spondyloarthritis) and compare with the current stand-of-care \[18F\]-FDG PET/CT

This description comes directly from the study's public registry record.

Talk to the study team

Lennert Boeckxstaens, MD · +0032 16 34 37 15 · lennert.boeckxstaens@uzleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Leuven

Leuven, Belgium

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07535554